PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression

• Main Authors: Deng, Shuo, Leong, Hin Chong, Datta, Arpita, Gopal, Vennila, Kumar, Alan Prem, Yap, Celestial T
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Review
• Language: English
• Published: MDPI 2023
• Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology; PI3K; AKT; cytoskeleton; cancer; chemotherapy; clinical trial; PHASE-II TRIAL; IXABEPILONE PLUS CAPECITABINE; AKT INHIBITOR IPATASERTIB; RESISTANT PROSTATE-CANCER; ALBUMIN-BOUND PACLITAXEL; ANTIBODY-DRUG CONJUGATE; BREAST-CANCER; INTERMEDIATE-FILAMENTS; CELL-MIGRATION; PHOSPHOINOSITIDE 3-KINASES
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/237212
• Institution: National University of Singapore

10.3390/cancers14071652